Y&R Capital

Y&R Capital, established in May 2015, is a venture capital firm based in Beijing, China, focused on high-tech incubation and service management. It was jointly founded by Zhejiang Ganzhan Investment Management Co., Ltd. and Beijing Bochuang Xingsheng Technology Co., Ltd. The firm emphasizes investment in strategic emerging industries, particularly in the fields of medical health, artificial intelligence, robotics, and intelligent manufacturing. Y&R Capital aims to identify and support innovative companies that exhibit growth potential in these sectors, aligning its investment strategy with the evolving technological landscape.

Ruijun Zhang Ph.D

Founding Partner and CEO

Past deals in Asia

Beijing Weiying Technology

Series A in 2022
Beijing Weiying Technology operates an online movie ticket booking platform known as WePiao, which is integrated within WeChat. The company collaborates with over 2,000 movie theaters across China, including major cinema chains like Wanda. Founded in 2014 by David Lim and headquartered in Beijing, Weiying Technology aims to diversify its offerings by expanding into other entertainment sectors, including online ticket booking for performances and sports events. The platform is designed to enhance user convenience by streamlining the ticket booking process for various events, enabling efficient access to entertainment options.

Arrays Medical Imaging

Series B in 2017
Beijing Arrays Medical Imaging Corporation (AMIC) is a company focused on the development, production, and sales of advanced medical molecular imaging devices. Located in the Zhongguancun Fengtai Hi-Tech Park, AMIC specializes in multi-modality imaging systems, including PET/CT, SPECT, and animal imaging devices, which are essential for new drug development and biomedical research. One of its notable products is the RAYSCAN-64 PET/CT scanner, an integrated imaging system designed to enhance the diagnosis of cancer, brain, and heart diseases. This device effectively combines functional images from PET with anatomical images from CT, resulting in high-quality, clear diagnostic images. The RAYSCAN-64 has undergone clinical validation and has received positive feedback from medical professionals, particularly at PLA 301 Hospital, highlighting its competitive performance relative to international products.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.